These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1375405)

  • 21. Cross-reactive and serotype-specific antibodies against foot-and-mouth disease virus generated by different regions of the same synthetic peptide.
    Doel TR; Doel CM; Staple RF; DiMarchi R
    J Virol; 1992 Apr; 66(4):2187-94. PubMed ID: 1372368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antigenic structure of the foot-and-mouth virus. V. Protection of naturally susceptible animals from foot-and-mouth disease using a synthetic peptide].
    Iarov AV; Gel'fanov VM; Grechaninova LA; Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Driagalin NN; Ivaniushchenkov VM
    Bioorg Khim; 1989 Oct; 15(10):1313-7. PubMed ID: 2561049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization against foot-and-mouth disease with synthetic peptides representing the C-terminal region of VP1.
    Doel TR; Gale C; Brooke G; DiMarchi R
    J Gen Virol; 1988 Sep; 69 ( Pt 9)():2403-6. PubMed ID: 2457649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D.
    García-Briones MM; Blanco E; Chiva C; Andreu D; Ley V; Sobrino F
    Virology; 2004 May; 322(2):264-75. PubMed ID: 15110524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
    Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic peptide vaccines: foot-and-mouth disease virus as a model.
    Sobrino F; Blanco E; García-Briones M; Ley V
    Dev Biol Stand; 1999; 101():39-43. PubMed ID: 10566773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orientation of epitopes influences the immunogenicity of synthetic peptide dimers.
    Cox JH; Ivanyi J; Young DB; Lamb JR; Syred AD; Francis MJ
    Eur J Immunol; 1988 Dec; 18(12):2015-9. PubMed ID: 2464496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of peptides for immunization against foot-and-mouth disease.
    Brown F
    Vaccine; 1988 Apr; 6(2):180-2. PubMed ID: 2838987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a major antibody binding epitope in the non-structural protein 3D of foot-and-mouth disease virus in cattle and the development of a monoclonal antibody with diagnostic applications.
    Yang M; Clavijo A; Li M; Hole K; Holland H; Wang H; Deng MY
    J Immunol Methods; 2007 Apr; 321(1-2):174-81. PubMed ID: 17320098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.
    McKenna TS; Rieder E; Lubroth J; Burrage T; Baxt B; Mason PW
    J Biotechnol; 1996 Jan; 44(1-3):83-9. PubMed ID: 8717390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Synthetic peptides simulating the protective epitopes of VP1 protein of foot-and-mouth disease virus type O and A].
    Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Ivaniushchenkov VN
    Bioorg Khim; 1987 Aug; 13(8):1132-5. PubMed ID: 2445357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
    Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
    Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
    Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
    Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).
    Fox G; Parry NR; Barnett PV; McGinn B; Rowlands DJ; Brown F
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():625-37. PubMed ID: 2543752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodies.
    Briand JP; Benkirane N; Guichard G; Newman JF; Van Regenmortel MH; Brown F; Muller S
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12545-50. PubMed ID: 9356486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge.
    Rodriguez LL; Barrera J; Kramer E; Lubroth J; Brown F; Golde WT
    Vaccine; 2003 Sep; 21(25-26):3751-6. PubMed ID: 12922108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection conferred by TrpE fusion proteins containing portions of the C-terminal region of capsid protein VP1 of foot-and-mouth disease virus.
    Giavedoni LD; Kaplan G; Marcovecchio F; Piccone ME; Palma EL
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():967-71. PubMed ID: 1849980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antigenic structure of foot-and-mouth virus. IV. Synthesis and immunogenic properties of new fragments of the VP1 protein of food-and-mouth virus strain A22].
    Iarov AV; Gel'fanov VM; Grechaninova LA; Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Lugovskoĭ AA; Driagalin NN; Ivaniushchenkov VN
    Bioorg Khim; 1989 Sep; 15(9):1193-205. PubMed ID: 2556150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antigenic structure of the foot-and-mouth-disease virus. I. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth virus type O1K].
    Surovoĭ AIu; Vol'pina OM; Snetkova EV; Volkova TD; Ivanov VT
    Bioorg Khim; 1988 Oct; 14(10):1352-62. PubMed ID: 2852937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amino acid changes outside the G-H loop of capsid protein VP1 of type O foot-and-mouth disease virus confer resistance to neutralization by antipeptide G-H serum.
    Krebs O; Ahl R; Straub OC; Marquardt O
    Vaccine; 1993; 11(3):359-62. PubMed ID: 7680514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.